Literature DB >> 6088394

In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

B D Meade, P D Kind, J B Ewell, P P McGrath, C R Manclark.   

Abstract

Lymphocytosis promoting factor (LPF) of Bordetella pertussis is a protein toxin which may have a role in the pathogenesis of pertussis. Since macrophages have an important role in the control of respiratory infections, the in vitro effects of LPF on macrophages from C3H/HeN and C3H/HeJ mice and on a murine macrophage-like cell line, RAW264, were examined. LPF inhibited random migration of resident peritoneal macrophages as well as the chemotaxis of peritoneal macrophages and the cell line. Fifty percent inhibition of chemotaxis occurred at 0.2 to 0.3 ng of LPF per ml for the macrophages and at 1 to 2 ng of LPF per ml for the cell line. When LPF was either heated at 80 degrees C for 5 min or premixed with specific antibodies, it failed to inhibit migration. At 20 ng/ml, LPF inhibited chemotaxis by more than 80% and also decreased Fc-mediated phagocytosis by 25 to 35%. At this dose, LPF was not a chemoattractant for murine macrophages and did not reduce macrophage viability, adherence, or opsonized zymosan-stimulated superoxide release. When LPF-treated macrophages were added to tissue culture dishes and then examined microscopically after 4 h, the LPF-treated cells adhered but failed to spread and elongate as well as control macrophages. These data indicate that LPF specifically inhibits macrophage migration in vitro and suggest that a possible role for LPF in pathogenesis is to inhibit migration of macrophages to the site of B. pertussis infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088394      PMCID: PMC263356          DOI: 10.1128/iai.45.3.718-725.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Cyclic AMP affects macrophage migration.

Authors:  E Pick
Journal:  Nat New Biol       Date:  1972-08-09

2.  Extraction and partial purification of the histamine-sensitizing factor of Bordetella pertussis.

Authors:  S B Lehrer; E M Tan; J H Vaughan
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  Structure of critical point dried oncornaviruses.

Authors:  E De Harven; D Beju; D P Evenson; S Basu; G Schidlovsky
Journal:  Virology       Date:  1973-10       Impact factor: 3.616

4.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

5.  Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.

Authors:  R D Sekura; F Fish; C R Manclark; B Meade; Y L Zhang
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

6.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

7.  Novel biological property of pertussis toxin: chemotactic activity on human monocytes.

Authors:  T Ogawa; H Takada; S Kotani; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

8.  Phagocyte strategy vs. microbial tactics.

Authors:  P Densen; G L Mandell
Journal:  Rev Infect Dis       Date:  1980 Sep-Oct

9.  Chemotaxis by mouse macrophage cell lines.

Authors:  R R Aksamit; W Falk; E J Leonard
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

10.  immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis.

Authors:  B D Geller; M Pittman
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

View more
  21 in total

1.  Role of pertussis toxin A subunit in neutrophil migration and vascular permeability.

Authors:  G A Brito; M H Souza; A A Melo-Filho; E L Hewlett; A A Lima; C A Flores; R A Ribeiro
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Cholera toxin inhibits chemotaxis by a cAMP-independent mechanism.

Authors:  R R Aksamit; P S Backlund; G L Cantoni
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

3.  Toward a new vaccine for pertussis.

Authors:  John B Robbins; Rachel Schneerson; Joanna Kubler-Kielb; Jerry M Keith; Birger Trollfors; Evgeny Vinogradov; Joseph Shiloach
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

4.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line.

Authors:  P S Backlund; B D Meade; C R Manclark; G L Cantoni; R R Aksamit
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Effects of adenylate cyclase toxin from Bordetella pertussis on human neutrophil interactions with Coccidioides immitis and Staphylococcus aureus.

Authors:  J N Galgiani; E L Hewlett; R L Friedman
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

7.  Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.

Authors:  M Oda; J L Cowell; D G Burstyn; S Thaib; C R Manclark
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

8.  Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.

Authors:  R L Friedman; R L Fiederlein; L Glasser; J N Galgiani
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Nico Van Rooijen; Victor I Ayala
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

Review 10.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.